Caveat emptor - Buyer beware

被引:0
|
作者
Wei, Norman S. [1 ]
机构
[1] Environmental Management and Training LLC, United States
关键词
Environmental impact - Environmental regulations - Plant shutdowns;
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The due diligence process is codified in the federal regulations as All Appropriate Inquiries (AAI), which is called a Phase 1 Environmental Assessment. To qualify for an ILO, the AAI must be performed or supervised by an Environmental Professional (EP). The AAI requires Historical documentation reviews, Visual inspections of the facility and adjoining properties, Environmental lien searches, and An assessment of the relationship of the purchase price to the fair market value of the property. A professionally prepared Phase 1 report will generally cost several thousand dollars or more, depending on the size and history of the commercial property. A recent Michigan case illustrates the risks associated with the failure to conduct proper due diligence. The buyers relied on the newspaper article and the sales brochure and did not perform their own due diligence before closing the deal. In this case, the jury determined that the buyers were partially responsible for their damages because they had failed to perform their own due diligence.
引用
收藏
相关论文
共 50 条
  • [1] Caveat emptor (buyer beware)
    Carruthers, JDA
    ARCHIVES OF DERMATOLOGY, 2002, 138 (09) : 1243 - 1244
  • [2] CAVEAT EMPTOR - LET THE BUYER BEWARE
    HILL, DW
    JOURNAL OF PHYSICS E-SCIENTIFIC INSTRUMENTS, 1984, 17 (01): : 5 - 6
  • [3] CAVEAT EMPTOR - LET (EDUCATIONAL) BUYER BEWARE
    TYLER, LL
    KLEIN, MF
    EDUCATIONAL TECHNOLOGY, 1973, 13 (04) : 52 - 54
  • [4] Eliminating poor quality medicines: 'Caveat' emptor, Caveat venditor' (buyer beware, seller beware)
    Breman, Joel G.
    INTERNATIONAL HEALTH, 2018, 10 (05): : 321 - 323
  • [5] The Physician's Relationship with the Pharmaceutical Industry: Caveat Emptor ... Buyer Beware!
    Albersheim, Susan G.
    Golan, Agneta
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (07): : 389 - 393
  • [6] Caveat emptor: Researcher beware
    Lieberman, JA
    Aghajanian, GK
    NEUROPSYCHOPHARMACOLOGY, 1999, 21 (04) : 471 - 473
  • [7] Caveat emptor: Editors beware
    McCann, UD
    Ricaurte, GA
    NEUROPSYCHOPHARMACOLOGY, 2001, 24 (03) : 333 - 334
  • [8] Caveat Emptor: Editors Beware
    Una D McCann
    George A Ricaurte
    Neuropsychopharmacology, 2001, 24 : 333 - 334
  • [9] Caveat Emptor: Researcher Beware
    Jeffrey A Lieberman
    George k Aghajanian
    Neuropsychopharmacology, 1999, 21 (4) : 471 - 473
  • [10] Caveat Emptor: Editors Beware
    Franz X Vollenweider
    Reese T Jones
    Matthew J Baggott
    Neuropsychopharmacology, 2001, 24 : 461 - 463